Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Broadcom
AVGO
|
$2.09B |
| 2 |
Mastercard
MA
|
$2.06B |
| 3 |
UnitedHealth
UNH
|
$1.3B |
| 4 |
Coca-Cola
KO
|
$1.17B |
| 5 |
Marsh & McLennan
MMC
|
$1.1B |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$1.55B |
| 2 |
Apple
AAPL
|
$1.51B |
| 3 |
JPMorgan Chase
JPM
|
$1.34B |
| 4 |
General Dynamics
GD
|
$1.25B |
| 5 |
Wells Fargo
WFC
|
$1.17B |
Sector Composition
| 1 | Technology | 21.49% |
| 2 | Healthcare | 18.42% |
| 3 | Financials | 15.97% |
| 4 | Consumer Discretionary | 9.49% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Afya
AFYA
$1.37B
| $936K | ﹤0.01% |
52,203
| – | – |
|
1627
West Fraser Timber
WFG
$5.94B
| $931K | ﹤0.01% |
+12,125
| New | +$931K |
|
1628
Warner Bros
WBD
$30.2B
| $924K | ﹤0.01% |
86,071
+30,854
| +56% | +$331K |
|
1629
Atea Pharmaceuticals
AVIR
$261M
| $911K | ﹤0.01% |
304,530
+86,021
| +39% | +$257K |
|
1630
Stoke Therapeutics
STOK
$1.19B
| $904K | ﹤0.01% |
135,960
+1,148
| +0.9% | +$7.63K |
|
1631
Y-mAbs Therapeutics
YMAB
$390M
| $904K | ﹤0.01% |
204,052
+70,789
| +53% | +$314K |
|
|
ORKA
1632
Oruka Therapeutics, Inc. Common Stock
ORKA
$583M
| $898K | ﹤0.01% |
87,501
-7,588
| -8% | -$77.9K |
|
1633
Terns Pharmaceuticals
TERN
$621M
| $886K | ﹤0.01% |
321,163
+98,649
| +44% | +$272K |
|
1634
Monte Rosa Therapeutics
GLUE
$296M
| $871K | ﹤0.01% |
187,731
-34,010
| -15% | -$158K |
|
1635
Taysha Gene Therapies
TSHA
$887M
| $869K | ﹤0.01% |
625,198
+39,604
| +7% | +$55.1K |
|
1636
Best Buy
BBY
$16.4B
| $864K | ﹤0.01% |
11,744
+6,061
| +107% | +$446K |
|
1637
Acadia Pharmaceuticals
ACAD
$4.28B
| $860K | ﹤0.01% |
51,775
-3,937
| -7% | -$65.4K |
|
1638
Trump Media & Technology Group
DJT
$4.71B
| $858K | ﹤0.01% |
43,919
| – | – |
|
1639
Celcuity
CELC
$2.51B
| $858K | ﹤0.01% |
84,825
+22,049
| +35% | +$223K |
|
1640
Anika Therapeutics
ANIK
$129M
| $856K | ﹤0.01% |
56,973
+17,188
| +43% | +$258K |
|
1641
Voyager Therapeutics
VYGR
$231M
| $856K | ﹤0.01% |
253,314
-7,937
| -3% | -$26.8K |
|
1642
OP Bancorp
OPBK
$216M
| $845K | ﹤0.01% |
70,299
-1,187
| -2% | -$14.3K |
|
|
BOLD
1643
Boundless Bio
BOLD
$26.2M
| $840K | ﹤0.01% |
556,233
| – | – |
|
|
ITOS
1644
DELISTED
iTeos Therapeutics
ITOS
| $837K | ﹤0.01% |
140,119
+29,787
| +27% | +$178K |
|
1645
Yum! Brands
YUM
$40.5B
| $826K | ﹤0.01% |
5,247
+2,632
| +101% | +$414K |
|
1646
LiveRamp
RAMP
$1.83B
| $818K | ﹤0.01% |
31,306
| – | – |
|
1647
Surmodics
SRDX
$463M
| $815K | ﹤0.01% |
+26,700
| New | +$815K |
|
1648
Astria Therapeutics
ATXS
$415M
| $815K | ﹤0.01% |
152,611
+4,562
| +3% | +$24.4K |
|
1649
Aura Biosciences
AURA
$406M
| $814K | ﹤0.01% |
138,952
+7,898
| +6% | +$46.3K |
|
1650
iShares MSCI France ETF
EWQ
$386M
| $814K | ﹤0.01% |
+20,446
| New | +$814K |
|